Status:
RECRUITING
A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Central Centrifugal Cicatricial Alopecia
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
Central centrifugal cicatricial alopecia (CCCA) is form of scarring hair loss that predominately affects middle-aged women of African descent.1 . Clinically, the natural progression of CCCA starts at ...
Detailed Description
The purpose of this pilot study is to determine if the Revian Red All LED cap shows potential to be an effective treatment for CCCA by recruiting hair follicles back to anagen growth or by improving i...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Women who are eighteen years of age or older with a biopsy-proven diagnosis of CCCA Stage II-III. They also must be on stable treatment without changes (on doxycycline, topical steroids, minoxidil and/or post 8 rounds of intralesional steroids) for at least 3 months.
- Subjects will be recruited from outpatient dermatology clinics at the Wake Forest Baptist Health Department of Dermatology.
- Exclusion Criteria
- Subjects with other forms of hair loss that is not CCCA
- Prior treatment with light source for alopecia
- Males are excluded from this study since the prevalence of CCCA in males is so significantly low that it is difficult to find cases in a clinical setting
Exclusion
Key Trial Info
Start Date :
July 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04764331
Start Date
July 6 2021
End Date
April 1 2026
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest School of Medicine - Dermatology Clinic
Winston-Salem, North Carolina, United States, 27157